Publications:

Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progression.

Scientific Reports

Chen, Yang Y; Zhang, Qin Q; Wang, Qiuyan Q; Li, Jie J; Sipeky, Csilla C; Xia, Jihan J; Gao, Ping P; Hu, Yanling Y; Zhang, Haiying H; Yang, Xiaobo X; Chen, Haitao H; Jiang, Yonghua Y; Yang, Yuehong Y; Yao, Ziting Z; Chen, Yinchun Y; Gao, Yong Y; Tan, Aihua A; Liao, Ming M; Schleutker, Johanna J; Xu, Jianfeng J; Sun, Yinghao Y; Wei, Gong-Hong GH; Mo, Zengnan Z

Publication Date: 2017-07-03

Variant appearance in text: rs2684779

PubMed Link: 28674394

Variant Present in the following documents:

• Main text
• 41598_2017_Article_4731.pdf

View BVdb publication page